Matthew Lumley
Vorstandsvorsitzender bei Myosana Therapeutics, Inc.
Profil
Matthew Lumley is currently the Chief Executive Officer at Myosana Therapeutics, Inc. and a Venture Partner at Medicxi Ventures (Jersey) Ltd.
He completed his undergraduate degree at Imperial College London in 2007 and his doctorate degree at King's College London in 2015.
Aktive Positionen von Matthew Lumley
Unternehmen | Position | Beginn |
---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 01.01.2023 |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.11.2021 |
Ausbildung von Matthew Lumley
Imperial College London | Undergraduate Degree |
King's College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
Myosana Therapeutics, Inc.
Myosana Therapeutics, Inc. BiotechnologyHealth Technology Myosana Therapeutics, Inc. is a biotech company develops novel platform technology. The company was founded by Stan Froehner, Nick Whitehead and Steve Runnels and is headquartered in Seattle, WA. | Health Technology |